Purpose: To determine whether cross-linked actin networks (CLANs) formed in dexamethasone (DEX)-treated human trabecular meshwork (HTM) cells are structurally similar to those formed after β3 integrin activation and involve αvβ3 integrin signaling.
Methods: Two HTM cell strains and an αvβ3 integrin-overexpressing immortalized TM cell line were used. DEX- or ethanol-pretreated HTM cells were plated on fibronectin with or without β3 integrin-activating mAb AP-5. Immunofluorescence microscopy was used to identify phalloidin-labeled CLANs and to ascertain the presence of α-actinin, PIP(2), and syndecan-4 within them. β3 Integrin signaling involvement was determined using a PI3-kinase (LY294002) or Rac1 (NSC23766) inhibitor. αvβ3 Integrin expression levels and the β3 integrin activation state were determined by fluorescence-activated cell sorter analysis and immunofluorescence microscopy.
Results: CLANs associated with either DEX treatment or β3 integrin activation contained syndecan-4, PIP(2), and α-actinin. In the absence of mAb AP-5, LY294002 did not affect DEX-associated CLAN formation, whereas NSC23766 decreased the percentage of CLAN-positive cells by 80%. In the presence of mAb AP-5, both inhibitors decreased DEX-associated CLAN formation. DEX pretreatment increased β3 integrin-induced CLAN formation nearly sixfold and the level of αvβ3 integrin expression and activation threefold compared with control cells. Activated β3 integrin-positive adhesions increased nearly fivefold in DEX-treated cells. αvβ3 Integrin overexpression in TM-1 cells increased CLAN formation twofold.
Conclusions: DEX-associated CLANs were structurally similar to those induced by mAb AP-5 and involved both increased expression and activation of αvβ3 integrins. Thus, glucocorticoid-induced CLAN formation may involve enhanced β3 integrin signaling in HTM cells, possibly by an inside-out signaling mechanism.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109009 | PMC |
http://dx.doi.org/10.1167/iovs.10-6618 | DOI Listing |
Blood Adv
September 2023
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!